⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3571371 | 0.83 | DYRK1A (0.35) | — | |
| SCHEMBL667243 | 0.78 | JAK2 (0.33) | — | |
| SCHEMBL7876670 | 0.77 | — | — | |
| SCHEMBL11894063 | 0.77 | — | — | |
| SCHEMBL27952254 | 0.77 | NCF1 (0.39) | — | |
| SCHEMBL8944768 | 0.77 | — | — | |
| SCHEMBL5985571 | 0.77 | — | — | |
| SCHEMBL19692379 | 0.77 | — | — | |
| N4-Hydroxycytosine SCHEMBL48396 | 0.77 | — | — | |
| SCHEMBL4492969 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4056711-B1 | METHOD FOR GENERATING APTAMERS WITH IMPROVED OFF-RATES | SOMALOGIC OPERATING CO INC (US) | 2025-09-03 | — | — | EP | claimed |
| EP-2172566-B2 | Method for generating aptamers with improved off-rates | SOMALOGIC INC (US) | 2022-05-18 | — | — | EP | claimed |
| EP-4638779-A1 | STERILISED APPARATUS FOR CAPTURING NUCLEIC ACIDS FROM BODY FLUIDS | Biocaptiva Limited (GB) | 2025-10-29 | — | — | EP | disclosed |
| CN-118974277-A | Nucleic acid amplification with higher exponential radix than radix 2 using high and low Tm primers | 赛沛公司 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024134208-A1 | STERILISED APPARATUS FOR CAPTURING NUCLEIC ACIDS FROM BODY FLUIDS | BIOCAPTIVA LIMITED (GB) | 2024-06-27 | — | — | WO | disclosed |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2024-05-23 | — | — | US | disclosed |
| CN-117982528-A | Application of schisandra chinensis polysaccharide in preparation of medicines for relieving DSS-induced ulcerative colitis of mice | 江苏农牧科技职业学院 | 2024-05-07 | — | — | CN | disclosed |
| US-11976309-B2 | Fusion proteins and methods for site-directed genome editing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-07 | — | — | US | disclosed |
| CN-117731769-A | Nucleic acid vaccine for Varicella Zoster Virus (VZV) | 摩登纳特斯有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117586413-A | Heteromultimeric proteins and methods of making the same | 三生国健药业（上海）股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-114667297-B | Antibody fusion protein, preparation method thereof and application thereof in resisting tumor | 三生国健药业（上海）股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| EP-1784188-A2 | FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | Merck & Co., Inc. (US) | 2007-05-16 | — | — | EP | disclosed |
| US-20070037771-A1 | Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine, removing hydroxyl protecting groups | MERCK SHARP & DOHME CORP. | 2007-02-15 | — | — | US | disclosed |
| WO-2006070004-A1 | COMPOUNDS USEFUL IN THE TREATMENT OF HIV | MEDIVIR AB (SE) | 2006-07-06 | — | — | WO | disclosed |
| WO-2006023750-A2 | FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | MERCK & CO., INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| EP-1594882-A1 | PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES | Merck & Co., Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| US-20050158770-A1 | Microwave mediated synthesis of nucleic acid probes | VENTANA MEDICAL SYSTEMS, INC. (US) | 2005-07-21 | — | — | US | disclosed |
| WO-2005064018-A2 | MICROWAVE MEDIATED SYNTHESIS OF NUCLEIC ACID PROBES | VENTANA MEDICAL SYSTEMS, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| WO-2004072090-A1 | PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES | MERCK & CO. INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-0209996-A2 | Nucleic acid probes comprising N4 -(substituted amino)cytidines | SISKA DIAGNOSTICS,INC. (US) | 1987-01-28 | — | — | EP | disclosed |